NCT06429020 - Sonography for COVID-19 Vaccines Related Reactive Lymphadenopathy | Biotech Hunter

Enrollment

1,089

Participants

Timeline

Start Date

January 1, 2023

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2023

Conditions

Reactive Axillary Lymphadenopathy for SARS-CoV-2 Vaccines in the Asian Taiwanese Population

Interventions

BIOLOGICAL

the AstraZeneca ChAdOx1 (AZ) vaccine, Moderna mRNA-1273 (Moderna) vaccine, and Pfizer-BioNTech BNT162b2 (BNT) vaccine.

record the condition of vaccination

Trial Locations (1)

ChiMei Medical Center, Tainan City